A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination-Reference-Cited by-同舟云学术

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Published:2018-01 Issue: Volume:270 Page:1-13
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Junkins Robert D.,Gallovic Matthew D.,Johnson Brandon M.,Collier Michael A.,Watkins-Schulz Rebekah,Cheng Ning,David Clément N.,McGee Charles E.,Sempowski Gregory D.,Shterev Ivo,McKinnon Karen,Bachelder Eric M.,Ainslie Kristy M.,Ting Jenny P.-Y.

Funder

UNC internal funds

National Science Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference82 articles.

1. Influenza, Seasonal. Fact Sheet;T.W.H. Organization,2016

2. The annual impact of seasonal influenza in the US: measuring disease burden and costs;Molinari;Vaccine,2007

3. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis;Osterholm;Lancet Infect. Dis.,2012

4. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study;Kissling;Euro Surveill.,2013

5. Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults;Yang;Drugs,2013

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-adjuvant nanovaccine platform based on targeted delivery of specific antigens for cancer immunotherapy;Nano Today;2024-12

2. Manganese‐Modified Aluminum Adjuvant Enhances both Humoral and Cellular Immune Responses;Advanced Healthcare Materials;2024-08-23

3. Intradermal vaccination with a phytoglycogen nanoparticle and STING agonist induces cytotoxic T lymphocyte-mediated antitumor immunity;npj Vaccines;2024-08-17

4. Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine;Journal of Controlled Release;2024-08

5. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses;mSphere;2024-07-30